


HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers
HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers May 13, 2025 View on the FDA Website The U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) announced the launch of a public Request for...
FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities
May 06, 2025 Today, the U.S. Food and Drug Administration announced its intent to expand the use of unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines, and other medical products intended for American consumers and...
EAS Consulting Group Expands Expertise with the Addition of Two Former FDA Staffers
EAS Consulting Group is pleased to announce the addition of two highly accomplished former FDA staff members, Gabriel Muñiz and Adam Orr, to its team of independent consultants. Their expertise in regulatory compliance and experience in the FDA’s tobacco and animal feed sectors will further strengthen EAS’s ability to provide superior guidance to clients navigating complex regulatory landscapes.
